FDA Investigator: Reyes Candau-Chacon

- Reyes Candau-Chacon first started conducting FDA inspections in 2012, with the last inspection in 2019. Over that time, Reyes Candau-Chacon has conducted 38 inspections at 34 companies across 37 sites.

Documents

FDA 483 AGC Biologics A/S, Soborg | 2019

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Lonza AG, Visp | 2019

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 3p Biopharmaceuticals S.L., Noain | 2019

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 BSP Pharmaceuticals Srl, Latina | 2018

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Immunomedics, Inc., Morris Plains | 2018

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Sanofi Chimie, Division of Sanofi, Vitry Sur Seine | 2018

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Hospira Zagreb d.o.o., Brdovec | 2018

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 N.v. Organon, Oss | 2017

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Biocon Limited, Bangalore | 2017

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Biocon Limited, Work Site I, Hebbagodi Bangalore | 2017

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Merck Serono SA (Vevey), Corsier-sur-Vevey | 2016

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Genentech, Inc., Vacaville | 2016

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Samsung Biologics Co., Ltd., Yeonsu-gu | 2016

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Immunex Rhode Island Corporation, West Greenwich | 2016

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Sandoz GmbH, Kundl | 2016

Out-of-stock
Reyes Candau-Chacon
Biologic Form 483

FDA 483 Sandoz GmbH, Langkampfen | 2016

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 F. Hoffmann-LaRoche Ltd., Basel | 2016

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 UCB Farchim SA, Bulle | 2015

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Boehringer Ingelheim Pharma Gmbh & Co Kg, Biberach An Der Riss | 2015

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Regeneron Pharmaceuticals Inc, Rensselaer | 2015

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Celltrion Inc., Incheon City | 2015

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Celltrion Inc., Incheon City | 2015

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Lonza Biologics Plc, Slough | 2014

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Werthenstein Biopharma Gmbh, Schachen | 2014

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Janssen Biologics B.V., Leiden | 2013

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 AbbVie Research Bioresearch Center, Worcester | 2013

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Biogen Idecs (Denmark) Manufacturing ApS, Hiller Dhiller D | 2013

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Biogen Idec (Denmark) Manufacturing ApS, Hillerod | 2013

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Lonza AG, Visp | 2012

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483

FDA 483 Roche Diagnostics GmbH, Penzberg | 2012

Out-of-stock
Reyes Candau-Chacon
Human Drug Form 483